# Livtencity

NDC: 64764-800
Generic name: MARIBAVIR
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20211123

FDA application: NDA215596

## Active ingredients

- MARIBAVIR: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-800"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-800
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0